Wang Jihua, chairman of Wanfu Biotech, said during a micro-interview with Securities Times · e Company that Wanfu Biotech has experienced many years of rapid development and has now moved from “large-scale growth” to “qualitative growth,” from “extensive management” to “scientific farming,” and from “focusing on material factors” to “focusing on talent and technical elements”; pursuing profitable income, profit with cash flow, and cash flow with return on investment, effectively improving cost efficiency, efficiency, and turnover, and continuously creating value for society and shareholders. Wanfu Biotech still has a lot of room for growth in the future.